医学
肝病学
慢性肝炎
公共卫生
乙型肝炎
肝炎
中国
病毒性肝炎
重症监护医学
家庭医学
内科学
免疫学
病理
病毒
政治学
法学
出处
期刊:PubMed
日期:2022-12-20
卷期号:30 (12): 1309-1331
被引量:44
标识
DOI:10.3760/cma.j.cn501113-20221204-00607
摘要
In order to update the prevention, diagnosis and treatment of chronic hepatitis B, and to achieve the goal of "eliminating viral hepatitis as a major public health threat by 2030" set by World Health Organization, Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association, organized experts in 2022 to update and the guidelines for prevention and treatment of chronic hepatitis B in China (version 2022). Under the idea of more extensive screening, more active prevention and antiviral treatment, we provide latest evidence and recommendations in the prevention, diagnosis and treatment of chronic hepatitis B in China.为了规范和更新慢性乙型肝炎的预防、诊断和抗病毒治疗,实现世界卫生组织提出的“2030年消除病毒性肝炎作为公共卫生危害”目标,中华医学会肝病学分会和感染病学分会于2022年组织国内有关专家,以国内外慢性乙型肝炎病毒感染的基础和临床研究进展为依据,结合我国的实际情况,更新形成了《慢性乙型肝炎防治指南(2022年版)》。以更广泛进行筛查、更积极预防和抗病毒治疗为原则,为慢性乙型肝炎的预防、诊断和治疗提供重要依据。.
科研通智能强力驱动
Strongly Powered by AbleSci AI